INDOCO REMEDIES LTD. - 532612 - Certification Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024
Certificate received from A.Y. Sathe & Co., Practicing Company Secretaries, certifying compliance with Regulation 40(9) read with Regulation 40(10) of the SEBI (LODR)Regulations,2015 for the year ended 31-03-2024. INDOCO REMEDIES LTD. - 532612 - Compliance Certificate Under Regulation 7(3) Of Securities & Exchange Board Of India (LODR)Regulations,2015 For The Year Ended 31-03-2024
Pursuant to provisions of Regulation 7(3) of the Securities and Exchange Board of India (LODR)Regulations,2015, as amended , we are enclosing herewith the Compliance Certificate duly signed by Link Intime India Pvt Ltd, Registrar & Transfer Agent and the Compliance officer of the Company, for the year ended 31-03-2024. INDOCO REMEDIES LTD. - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate issued by Link Intime India Private Limited Registrar and Transfer Agent of the Company, confirming compliance under Reg 74(5) of SEBI (DP)Reg,2018 for the qtr ended 31-03-2024 INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Corporate Guarantee For Warren Remedies Private Limited, Wholly Owned Subsidiary Of The Company.
Pursuant to Regulation 30 of SEBI (LODR) Regulations,2015, we would like to inform you that the Committee of Executive Directors at its meeting held on 05-04-2024 approved the Corporate Guarantee upto maximum principal amount of Rs.25 Crores in favour of HDFC Bank Ltd in respect of the Loan /credit facilities to be availed in tranches by Warren Remedies Private Ltd, wholly owned subsidiary of the Company. INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Cessation
Mr. Divakar Gavaskar and Mr. Rajiv Kakodkar shall cease to be an Independent Directors of the Company upon completion of two(2) consecutive terms of five(5) years each at the closure of business hours on 31st March, 2024. INDOCO REMEDIES LTD. - 532612 - Intimation Of Appointment Of Secretarial, Internal And Cost Auditor Of The Company For The Financial Year 2024-25
The Board of Directors in its meeting held today i.e. 29th March, 2024 has interalia considered and approved the re-appointment of following auditors for the financial year 2024-2025. 1. M/s A.Y.Sathe & Co., Practicing Company Secretaries as Secretarial Auditor. 2. M/s. B. K. Khare & Co. Chartered Accountants as Internal Auditor. 3. M/s Joshi Apte and Associates, Cost Accountants as Cost Auditor. INDOCO REMEDIES LTD. - 532612 - Intimation Of Grant Of Stock Options And Restricted Stock Units Under Indoco Remedies Limited Employee Stock Option Plan - 2022
Grant of 90,000 Employee Stock Options and 13,000 Restricted Stock Units under the Indoco Remedies Limited Employee Stock Option Plan 2022 INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 31,850 Equity Shares under Indoco Remedies Limited Employee Stock Option Plan-2022 INDOCO REMEDIES LTD. - 532612 - Closure of Trading Window
Pursuant to the provisions of SEBI (PIT)Regulations,2015 and Company''s code of conduct for regulating , monitoring and reporting of trading by insiders, this is to inform you that the Trading Window for trading/dealing in Equity Shares of the Company will remain closed from Monday, 01st April, 2024 until 48 hours after declaration of Audited Standalone & Consolidated Financial Results of the Company for the quarter & year ended 31-03-2024. Indoco Remedies' subsidiary commences production of pharmaceutical intermediates
The company recently approved purchase of land at Mahal Industrial Estate in Andheri, Mumbai, for its expansion plans